King licenses US sales rights to cyanide antidote
King Pharmaceuticals licenses US sales rights for cyanide antidote from Germany-based Merck
- On 12:57 pm EDT, Tuesday October 27, 2009
BRISTOL, Tenn. (AP) -- King Pharmaceuticals Inc. said Tuesday it licensed rights to sell cyanide poisoning antidote Cyanokit from a unit of Germany-based Merck KGaA for undisclosed terms.
The company has rights to market and sell the product in the U.S. Cyanide poisoning is typically caused by smoke inhalation from fires.
Cyanokit will be sold and distributed through Meridian Medical Technologies Inc., a unit of King Pharmaceuticals.
Shares of King Pharmaceuticals rose 18 cents to $10.51 in afternoon trading.
Related Headlines
- Your First Move For Friday November 27th - at CNBC
- Market Winners & Losers: King Pharmaceuticals, MBIA - at Fox Business
- Your First Move For Friday November 20th - at CNBC
- [video] Defense, Defense - at CNBC
- StockPreacher.com Issues Trading Outlook for Arena Pharmaceuticals Inc. - GlobeNewswire
Related Blog Headlines
- Monday Options Recap - at Seeking Alpha
- Which Drug Companies Could Be Private-Equity Targets? - at The Wall Street Journal Online
- Thursday Options Update: ETFC, MA, V, RF, KG & HW - at Seeking Alpha
- King Pharma Income Statement Analysis for September 2009 Quarter - at Seeking Alpha
- King Beats, but Earnings Down - Zacks.com
Sponsored Links
-
Yahoo Personal Free Trial
Sign Up for a 7 Day Free Trial. Start Emailing, Flirting & Dating. -
Independent Advisor Broker/Dealer
Discover The Many Benefits Of Independence With LPL Financial.
-
Compare Top CD Rates
Search CDs from 100s of Banks Plus News, Tips, Advice and More. -
Personal Finance Budgeting
What you need to know. Personal finance management tips and advice.
Tech Ticker Recent Posts
Add Alert Copyright © 2009 The Associated Press. All rights reserved. The information contained in the AP News report may not be published, broadcast, rewritten, or redistributed without the prior written authority of The Associated Press.